Cost Saving

Up to 56% savings on the cost of category C quetiapine XL  prescriptions by prescribing Biquelle XL.2**

By prescribing Biquelle XL by brand, the average savings for a CCG could be more than £52,795 per year providing the NHS with a total potential annual prescribing cost saving of more than £8.5 million.1*

Biquelle XL Cost Calculator

To find out how much you can save by prescribing Biquelle XL, please follow the instructions on the Biquelle XL calculator:

Biquelle XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • Up to 56% savings on Category C Drug Tariff prices;2**
  • Available from mainline wholesalers;
  • High level of stockholdings;
  • Price guaranteed until 2024***
  • Bioequivalent to the originator.3
ProductCategory C UK Drug Tariff price2Biquelle XL Price
Quetiapine prolonged-release tablets 50mg x 60 £67.66 £29.45
Quetiapine prolonged-release tablets 150mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 200mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 300mg x 60£170.00£74.45
Quetiapine prolonged-release tablets 400mg x 60£226.20 £98.95
Quetiapine prolonged-release tablets 600mg x 30 £70.73 £70.73
Potential still to save based on the market data in reference 1 for 161 CCGs switching their generic and brand originator quetiapine prolonged-release tablet prescriptions to Biquelle XL. **Based on 56% saving when prescribing Biquelle XL 50, 150, 200, 300 and 400mg tablets only, versus the cost of Category C quetiapine XL on the UK Drug Tariffs. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.
References: 1) Insypher data GPPLPD Date Range: Jun20 -Aug 20 MQT*4  2) May 2021 UK Drug Tariffs (Accessed May 2021). 3) Data on file. 1010067149 v 4.0 October 2019
For further information please call: 01730 231148,
email: or visit
Adverse events should be reported. Reporting forms and information can be found at
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Biquelle XL, please see the abbreviated prescribing information.

Revision reference – Biquelle XL_18_03.05.21

More products available
in this range:
Click to view their
individual websites